Release of biologically active TGF-β1 by alveolar epithelial cells results in pulmonary fibrosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 285, Issue 3 29-3, 2003, Pages

  Xu, Ying Dong ^a   Hua, Jiesong ^a   Mui, Alice ^b   O'Connor, Robert ^c   Grotendorst, Gary ^d   Khalil, Nasreen ^a,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b VANCOUVER GENERAL HOSPITAL   (Canada)

^c BRITISH COLUMBIA CANCER AGENCY   (Canada)

^d UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^e JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

Idiopathic pulmonary fibrosis; Transforming growth factor 1

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; COLLAGEN TYPE 6; PUROMYCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONTROLLED STUDY; COVALENT BOND; EPITHELIUM CELL; FEMALE; FIBROBLAST; GENETIC TRANSFECTION; IDIOPATHIC DISEASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; LUNG DISEASE; LUNG FIBROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVIEW; TISSUE SECTION;

EID: 0041677660     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00298.2002     Document Type: Review

References (49)

1. Adamson IY, Young L, and Bowden DH. Relationship of alveolar epithelial injury and repair to the induction of pulmonary fibrosis. Am J Pathol 130: 377-383, 1988.
2. Antoniades HN, Bravo MA, Avila RE, Galanopoulus T, Neville J, and Selman M. Platelet-derived growth factor in idiopathic pulmonary fibrosis. J Clin Invest 86: 1055-1064, 1990.
3. Bauer M and Schuppan D. TGF-β1 in liver fibrosis: time to change paradigms? FEBS Lett 502: 4-10, 2001.
4. Bitzer M, Sterzel RB, and Bottinger EP. Transforming growth factor-β in renal disease. Kidney Blood Press Res 21: 1-12, 1998.
5. Blanchette F, Day R, Dong W, Lapris MH, and Dubois CM. TGF-β1 regulates gene expression of its own converting enzyme furin. J Clin Invest 99: 1974-1983, 1997.
6. Blobe GC, Schiemann WP, and Lodish HF. Role of transforming growth factor β1 in human disease. N Engl J Med 342: 1350-1358, 2000.
7. Brenchley PE, Williams S, Coupes B, and Short CD. Strategies for meaningful measurement of circulating levels of transforming growth factor β1 in clinical samples. Transplantation 71: 1355-1356, 2001.
8. Brunner AM, Marquardt H, Malacko AR, Lioubin MN, and Purchio AF. Site directed mutagenesis of cysteine residues in the pro region of the transforming growth factor β1 precursor: expression and characterization of mutant proteins. J Biol Chem 264: 13660-13664, 1989.
9. Coultas DB, Zumwalt RE, Black WC, and Sobonya RE. The epidemiology of interstitial lung diseases. Am J Respir Crit Care Med 150: 967-972, 1994.
10. Demetriou M, Binkert C, Sukhu B, Tenenbaum HC, and Dennis JW. Fetuin/α2-HS glycoprotein is a transforming growth factor-β type II receptor mimic and cytokine antagonist. J Biol Chem 271: 12755-12761, 1996.
11. Eckes B, Zigrino P, Kessler D, Holtkotter O, Shephard P, Mauch C, and Krieg T. Fibroblast-rrLatrix interactions in wound healing and fibrosis. Matrix Biol 19: 325-332, 2000.
12. Fang KC. Mesenchymal regulation of alveolar repair in pulmonary fibrosis. Am J Respir Cell Mol Biol 23: 142-145, 2002.
13. Funderburgh JL, Funderburgh ML, Mann MM, Corpuz LM, and Roth MR. Proteoglycan expression during transforming growth factor β-induced keratocyte-myofibroblast transdifferentiation. J Biol Chem 276: 44173-44178, 2001.
14. Grogan T, Reinhardt K, Jaramillo M, and Lee D. An update on "special stain" histochemistry with emphasis on automation. Adv Anat Pathol 7: 110-122, 2000.
15. Gross TJ and Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 345: 517-525, 2001.
16. Grotendorst GR. Connective tissue growth factor: a mediator of TGF-β1 action on fibroblasts. Cytokine Growth Factor Rev 8: 171-179, 1997.
17. 2-terminal kinase-dependent pathway. Am J Respir Crit Care Med 1163: 152-157, 2001.
18. Hoffmann G, Grote J, Friedrich F, Mutz N, and Schobersberger W. The pulmonary epithelial cell line L2 as a new model for an inducible nitric oxide synthetase expressing distal airway epithelial cell. Biochem Biophys Res Commun 217: 575-583, 1995.
19. Khalil N. TGF-β: from latent to active. Microb Infect 1: 1255-1263, 1999.
20. Khalil N, Bereznay O, Sporn M, and Greenberg AH. Macrophage production of transforming growth factor-β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 170: 727-737, 1989.
21. Khalil N, Corne S, Whitman C, and Yacyshyn H. Plasmin regulates the activation of cell-associated latent TGF-β1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 15: 252-259, 1996.
22. Khalil N, O'Connor R, Flanders K, and Unruh H. TGF-β1 but not TGF-β2 or TGF-β3 is differentially present in epithelial cells of advanced pulmonary fibrosis: an immunohistochemical study. Am J Respir Cell Mol Biol 14: 131-138, 1996.
23. Khalil N, O'Connor R, Unruh H, Warren P, Kemp A, Bereznay O, Flanders K, and Greenberg AH. Increased production and immunohistochemical localization of transforming growth factor-β (TGF-β) in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol 5: 155-162, 1991.
24. Khalil N, Perkeh TV, O'Connor R, Antman N, Kepron W, Yehaulaeshet T, Xu YD, and Gold LI. The regulation of TGF-β1 in idiopathic pulmonary fibrosis by the activation of latent TGF-β1 and differential expression of TGF-β receptors (TβR-I and TβR-II). Thorax 56: 907-915, 2001.
25. Khalil N, Whitman C, Zuo L, Danielpour D, and Greenberg A. Regulation of alveolar macrophage transforming growth factor-β secretion by corticosteroids in bleomycin-induced pulmonary inflammation in the rat. J Clin Invest 92: 1812-1818, 1993.
26. Kitamura T. New experimental approaches in retroviral-mediated expression screening. Int J Hematol 67: 351-359, 1998.
27. Lawrence DA. Transforming growth factor-β: a general review. Eur Cytokine Netw 7: 363-364, 1996.
28. McCartney-Francis N, Mizel D, Wong H, Wahl L, and Wahl S, TGF-β regulates production of growth factors and TGF-β by human peripheral blood monocytes. Growth Factors 4: 27-35, 1990.
29. Miyazaki Y, Araki K, Vesin C, Garcia I, Kapanci Y, Whitsett JA, Piguet PF, and Vassalli P. Expression of a tumor necrosis factor-α transgene in murine lung causes lymphocytic and fibrosing alveolitis. A mouse model of progressive pulmonary fibrosis. J Clin Invest 96: 250-259, 1995.
30. Moussad EE and Brigstock DR. Connective tissue growth factor: what is in a name? Mol Genet Metab 71: 276-292, 2000.
31. Munger JS, Huang N, Kawakatsu H, Griffiths MJD, Dalton SL, Wu JJ, Pittel JF, Kamiski N, Garat C, Matthay MA, Rifkin DB, and Sheppard D. The integrin αvβ6 binds and activates latent-TGF-β1: mechanism for regulating pulmonary inflammation and fibrosis. Cell 96: 319-328, 1999.
32. Nash JR, McLaughlin PJ, Butcher D, and Corrin B. Expression of tumor necrosis factor-α in cryptogenic fibrosing alveolitis. Histopathology 22: 343-347, 1993.
33. Oldmixon EH, Carlsson K, Kuhn C III, Butler JP, and Hoppin FG Jr. Alpha-actin: deposition quantities and estimated effects on lung recoil and compliance. J Appl Physiol 91: 459-473, 2001.
34. Pan LH, Ohtani H, Yamauchi K, and Nagura H. Co-expression of TNF-α and IL-1 β in human acute pulmonary fibrotic diseases: an immunohistochemical analysis. Pathol Int 46: 91-99, 1996.
35. Raftery LA and Sutherland DJ. TGF-β family signal transduction in Drosophila development: from Mad to Smads. Dev Biol 210: 251-268, 1999.
36. Roy SG, Nozaki Y, and Phan SH. Regulation of α-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol 33: 723-734, 2001.
37. Selman M, King TE, and Pardo A. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151, 2001.
38. Selman M and Pardo A. Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 3: 3-11, 2002.
39. Shukla A, Meisler N, and Cutroneo KR. Perspective article: transforming growth factor-β: crossroad of glucocorticoid and bleomycin regulation of collagen synthesis in lung fibroblasts. Wound Repair Regen 7: 133-140, 1999.
40. Sime PJ, Xing Z, Graham FL, Casky KG, and Gauldie J. Adenovector-mediated gene transfer of active transforming growth factor-β1 induces prolonged severe fibrosis in rat lung. J Clin Invest 100: 768-776, 1997.
41. Sueoka N, Sueoka E, Miyazaki Y, Okabe S, Karosumi M, Takayama S, and Fujiki H. Molecular pathogenesis of interstitial pneumonitis with TNF-α transgenic mice. Cytokine 10: 124-131, 1998.
42. Sugahara K, Iyama K, Kuroda MJ, and Sano K. Double intratracheal instillation of keratinocyte growth factor prevents bleomycin-induced lung fibrosis in rats. J Pathol 186: 90-98, 1998.
43. Uh ST, Inoue Y, King TE Jr, Chan ED, Newman LS, and Riches DW. Morphometric analysis of insulin-like growth factor-1 localization in lung tissues of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 158: 1626-1635, 1998.
44. Wang G, Slepushkin VA, Bodner M, Zabner J, van Es HHG, Thomas P, Jolly DJ, Davidson BL, and McCray PB. Keratinocyte growth factor induced epithelial proliferation facilitates retroviral-mediated gene transfer to distal lung epithelia in vivo. J Gene Med 1: 22-30, 1999.
45. Wrana JL. TGF-β receptors and signalling mechanisms. Miner Electrolyte Metab 24: 120-130, 1998.
46. Xu YD, Douglas D, and Khalil N. Retrovirus mediated TGF-β1 gene (ser223 225) transfection of rat alveolar epithelial cells (AECs) results in the release of active TGF-β1 and regulation of DNA synthesis. Am J Respir Crit Care Med 163: A746, 2001.
47. Yano T, Mason RJ, Pan T, Deterding RR, Nielson LD, and Shannon JM. KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Am J Physiol Lung Cell Mol Physiol 279: L1146-L1158, 2000.
48. Yehualaeshet T, O'Connor R, Begleiter A, Murphy-Ullrich JE, Silverstein R, and Khalil N. A CD36 synthetic peptide inhibits bleomycin-induced pulmonary inflammation and connective tissue synthesis in the rat. Am J Respir Cell Mol Biol 23: 204-212, 2000.
49. Yehualaeshet T, O'Connor R, Green-Johnson J, Mai S, Silverstein R, Murphy-Ullrich JE, and Khalil N. Activation of rat alveolar macrophage-derived latent transforming growth factor-β1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36. Am J Pathol 155: 841-851, 1999.